Kardos P - Search Results

1

Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany.

Vogelmeier CF, Beeh KM, Kardos P, Paulsson T, Rohde G, Watz H, Compton C, Mohan T, Claussen J. Vogelmeier CF, et al. Among authors: kardos p. Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241287621. doi: 10.1177/17534666241287621. Ther Adv Respir Dis. 2024. PMID: 39436955 Free PMC article.

2

The 'real-life' COPD patient in Germany: The DACCORD study.

Worth H, Buhl R, Criée CP, Kardos P, Mailänder C, Vogelmeier C. Worth H, et al. Among authors: kardos p. Respir Med. 2016 Feb;111:64-71. doi: 10.1016/j.rmed.2015.12.010. Epub 2015 Dec 30. Respir Med. 2016. PMID: 26775251 Free article.

3

A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.

Kardos P, Vogelmeier C, Worth H, Buhl R, Lossi NS, Mailänder C, Criée CP. Kardos P, et al. Respir Med. 2017 Mar;124:57-64. doi: 10.1016/j.rmed.2017.02.007. Epub 2017 Feb 16. Respir Med. 2017. PMID: 28284322 Free article. Clinical Trial.

4

GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.

Worth H, Buhl R, Criée CP, Kardos P, Lossi NS, Vogelmeier CF. Worth H, et al. Among authors: kardos p. Respir Med. 2017 Oct;131:77-84. doi: 10.1016/j.rmed.2017.08.008. Epub 2017 Aug 9. Respir Med. 2017. PMID: 28947047 Free article.

5

Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA.

Kardos P, Mokros I, Sauer R, Vogelmeier CF. Kardos P, et al. Int J Chron Obstruct Pulmon Dis. 2018 May 3;13:1455-1468. doi: 10.2147/COPD.S159827. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29765213 Free PMC article. Clinical Trial.

6

Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.

Buhl R, Criée CP, Kardos P, Vogelmeier CF, Kostikas K, Lossi NS, Worth H. Buhl R, et al. Among authors: kardos p. Int J Chron Obstruct Pulmon Dis. 2018 Aug 24;13:2557-2568. doi: 10.2147/COPD.S169958. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30197512 Free PMC article.

7

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.

Vogelmeier CF, Worth H, Buhl R, Criée CP, Gückel E, Kardos P. Vogelmeier CF, et al. Among authors: kardos p. Respir Res. 2022 May 2;23(1):109. doi: 10.1186/s12931-022-02037-2. Respir Res. 2022. PMID: 35501806 Free PMC article.

8

In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.

Worth H, Buhl R, Criée CP, Kardos P, Gückel E, Vogelmeier CF. Worth H, et al. Among authors: kardos p. Respir Res. 2023 Jan 5;24(1):2. doi: 10.1186/s12931-023-02311-x. Respir Res. 2023. PMID: 36604646 Free PMC article.

9

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

Kardos P, Wencker M, Glaab T, Vogelmeier C. Kardos P, et al. Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9. doi: 10.1164/rccm.200602-244OC. Epub 2006 Oct 19. Am J Respir Crit Care Med. 2007. PMID: 17053207 Clinical Trial.

10

The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods.

Kardos P, Vogelmeier C, Buhl R, Criée CP, Worth H. Kardos P, et al. BMC Pulm Med. 2015 Jan 12;15:2. doi: 10.1186/1471-2466-15-2. BMC Pulm Med. 2015. PMID: 25578330 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters